A novel injectable selenium-containing hydrogel with antioxidant, antibacterial, and anti-inflammatory properties for topical treatment of allergic rhinitis

Colloids Surf B Biointerfaces. 2026 Jul:263:115590. doi: 10.1016/j.colsurfb.2026.115590. Epub 2026 Mar 3.

Abstract

Background: Allergic rhinitis (AR) is a prevalent inflammatory condition with complex pathophysiology and limited treatment options. Given the current lack of drugs with significant therapeutic effects, it is necessary to develop a hydrogel that can effectively control the nasal inflammation in AR.

Methods: An injectable and self-healing disulfide bond hydrogel was prepared by cross-linking L-selenocysteine (L-CySe) with carboxymethyl cellulose (CMC). The microstructure, porosity, swelling property, degradability, rheology and mechanical properties of the L-CySe/CMC (SeC) hydrogel were characterized. The antioxidant and antimicrobial activities were evaluated in vitro. The air-liquid interface (ALI) of human nasal epithelial cells stimulated by IL-4. The murine AR model was created by using ovalbumin (OVA). The histopathology of mice and ALI model was analyzed by hematoxylin and eosin (H&E) staining, PAS and Sirius red staining for eosinophils. The levels of OVA-specific IgE (OVA-sIgE) and type 2 cytokines were detected by using ELISA. The biosafety of SeC hydrogel was confirmed by hemolysis, Cell Counting 8 Kit (CCK-8 kit), Live/Dead staining and histopathological examination.

Results: SeC hydrogel features a uniform porous structure (porosity of 60.26%), an appropriate swelling/degradation curve, excellent mechanical strength (compressive modulus of 24.74 kPa), and rapid self-healing ability. In both models, it demonstrated a powerful free radical scavenging capacity (>66%), broad-spectrum antibacterial activity (>97% inhibition), and significant anti-inflammatory effects. Hydrogels have good blood compatibility (hemolysis rate <5%) and no cell and organ toxicity. In ALI stimulated by IL-4, it reduced epithelial thickness and inhibits goblet cell proliferation. In AR mice, it alleviated nasal symptoms, reduced epithelial thickening, eosinophil infiltration, goblet cell proliferation, and decreased the levels of OVA-sIgE and type 2 cytokines (IL-4, IL-5, IL-13).

Conclusion: SeC hydrogel provides an effective and promising treatment strategy for the effective treatment of allergic rhinitis by taking advantage of its synergistic antioxidant, antibacterial and anti-inflammatory properties.

Keywords: Allergic rhinitis; Anti-inflammatory; Hydrogel; Selenium.

MeSH terms

  • Administration, Topical
  • Animals
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Inflammatory Agents* / administration & dosage
  • Anti-Inflammatory Agents* / chemistry
  • Anti-Inflammatory Agents* / pharmacology
  • Antioxidants* / administration & dosage
  • Antioxidants* / chemistry
  • Antioxidants* / pharmacology
  • Humans
  • Hydrogels* / administration & dosage
  • Hydrogels* / chemistry
  • Hydrogels* / pharmacology
  • Injections
  • Mice
  • Mice, Inbred BALB C
  • Microbial Sensitivity Tests
  • Ovalbumin
  • Rhinitis, Allergic* / chemically induced
  • Rhinitis, Allergic* / drug therapy
  • Rhinitis, Allergic* / pathology
  • Selenium* / chemistry
  • Selenium* / pharmacology

Substances

  • Hydrogels
  • Antioxidants
  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Selenium
  • Ovalbumin